pdf

O’Melveny Adds Senior Counsel in Washington, DC, Office

January 04, 2016

FOR IMMEDIATE RELEASE

Contact:
Colleen B. McGushin
O’Melveny & Myers LLP
415.984.8825
cmcgushin@omm.com

 
WASHINGTON, DC ─ JANUARY 4, 2016 ─ O’Melveny & Myers LLP is pleased to announce that Seth Ray has joined the Firm in the Washington, DC, office as senior counsel and a member of the Product Liability & Mass Torts and Life Sciences Practices.

Ray is an accomplished lawyer who focuses his practice on matters involving pharmaceuticals, health care, and product liability, as well as on regulatory issues. He joins O’Melveny from the US Food and Drug Administration where he served for 26 years, most recently as Senior Advisor and Regulatory Counsel with the agency’s Office of Prescription Drug Promotion (OPDP). In that role, he provided expert legal and policy advice to senior OPDP managers on significant guidance documents, enforcement actions, legislative proposals, and other complex issues. Prior to that, Ray held several positions as an attorney in the FDA’s Office of Chief Counsel, including: Associate Deputy Chief Counsel for Drugs and Biologics, handling OPDP prescription drug advertising and promotion matters and supervising attorney counseling teams; Associate Chief Counsel for Drugs, providing legal counsel to the Center for Drug Evaluation and Research and other FDA components on drug approvals, prescription drug labeling, clinical trials, drug safety, off-label use, the Prescription Drug Marketing Act, and other compliance issues; and Associate Chief Counsel for Enforcement, responsible for all phases of civil (seizures and injunctions) and criminal (investigations and prosecutions) litigation in various product areas.

“We are thrilled Seth will bring his unique experience and talents to O’Melveny,” said partner Steve Brody, Co-Chair of the Firm’s Product Liability & Mass Torts Practice. “Having served at the FDA for many years, Seth’s understanding and knowledge of the pharmaceutical industry strengthens the Firm’s litigation and regulatory capabilities, especially for our roster of life sciences and health care clients.”

“I’m delighted to work with the exceptional lawyers at O’Melveny,” Ray said. “I was honored to serve in government, and now I look forward to helping our clients navigate the increasingly complex legal and business challenges they face.”

Before his work at the FDA, Ray served as an Assistant States Attorney (Broward County, Florida), an FBI Special Agent, and a Trial Attorney with the US Department of Justice (Tax Division).

About O’Melveny & Myers LLP
With approximately 700 lawyers in 15 offices worldwide, O’Melveny & Myers LLP helps industry leaders across a broad array of sectors manage the complex challenges of succeeding in the global economy. We are a values-driven law firm, guided by the principles of excellence, leadership, and citizenship. Our commitment to these values is reflected in our dedication to improving access to justice through pro bono work and championing initiatives that increase the diversity of the legal profession. For more information, please visit www.omm.com. 

###